Cancer Associated Thrombosis and Isoquercetin (CATIQ)
Clinical trial NCT02195232 · COMPLETED
Trial details
- NCT number
- NCT02195232
- Sponsor
- Jeffrey Zwicker, MD
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.